Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control
Online-Only Appendix
Files in this Data Supplement:
This Article
-
Diabetes Care December 2008 vol. 31 no. 12 2315-2317
- AbstractFree
- Full Text
- Full Text (PDF)
- » Online-Only Appendix
Current Issue
From the Cover
- Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
- Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program
- High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects
- Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation
